Therapeutics 2021
4 papers
Therapeutics 2021 featured research focused on diagnostic methodologies, clinical management strategies, and pharmacological optimization across several medical specialties. Notable studies explored the diagnostic utility of plasma biomarkers, such as miRNA-497 and cTnI, for identifying myocardial injury in pediatric sepsis cases. In ophthalmology, researchers investigated the clinical outcomes of patients with central retinal vein occlusion who missed follow-up appointments while receiving anti-vascular endothelial growth factor treatments.
The year's contributions also addressed specialized pharmacological needs and imaging techniques. This included expert consensus on the optimal use of perampanel for treating epilepsy in Asian patient populations. Additionally, research in oncology utilized morphological filtering techniques in computed tomography angiography to improve the visualization of the gastrocolic vein trunk for right colon cancer assessments. Prolific contributors to the 2021 edition included B. Shi, Chengjiao Huang, and Han Zhang, among others. These works reflect a broader trend toward refining diagnostic accuracy and tailoring treatment protocols to specific patient demographics and clinical scenarios.